- A symptom that might seem benign could indicate that a person who has already beaten COVID-19 is developing a scary, potentially deadly coronavirus complication.
- Adults are also at risk of developing the same multisystem inflammatory syndrome that has been seen in children who survived COVID-19.
- People who develop a skin rash a few weeks after clearing the COVID-19 infection might need immediate medical attention for a condition called MIS-A.
Scientists discover new organ in the throat – Live Science
A secret set of salivary glands has been hiding behind the nose.
Scientists have discovered a new organ: a set of salivary glands set deep in the upper part of the throat.
This nasopharynx region behind the nose
was not thought to host anything but microscopic, diffuse, salivary glands; but the newly discovered set are about 1.5 inches (3.9 centimeters) in length on average. Because of their location over a piece of cartilage called the torus tubarius, the discoverers of these new glands have dubbed them the tubarial salivary glands. The glands probably l…
Rheumatoid arthritis drug tocilizumab advances as a COVID treatment, as other regimens fall back, studies show – USA TODAY
The list of drugs effective at treating COVID-19 got longer Tuesday, even as another well-used drug lost some of its luster.
President Trump received mostly the same treatment as anyone would get for COVID-19, except for one experimental drug and the speed of his care.
The list of drugs shown effective for treating COVID-19 got longer Tuesday, even as another well-used drug lost some of its luster.
In a large clinical study, tocilizumab, an immune modulator long used to treat rheumatoid arthritis, showed it can save lives if given to critically ill COVID-19 patients within the first two days of being admi…
Volunteers to Be Infected With Coronavirus in Vaccine-Effectiveness Trials in U.K. – The Wall Street Journal
Controversial ‘human challenge’ trial would require injecting healthy humans with virus to gauge effectiveness of vaccines
LONDONU.K. researchers plan to start infecting healthy volunteers with tightly controlled doses of the coronavirus in early 2021 in what they called a first-of-its-kind effort to more rapidly gauge the effectiveness of multiple vaccines against Covid-19.The plans for so-called human-challenge trials target 18- to 30-year-olds who have been free of Covid-19 symptoms and show no other risk factors such as heart disease or diabetes, said the researchers, led by infectious-disease experts at Imperia…
- Business2 days ago
Heidi Heitkamp op-ed: Working-class voters, your ballot is your health, and the stakes are higher than ever – CNBC
- Technology21 hours ago
LG’s rollable OLED TV goes on sale for $87000 – Engadget
- Sports2 days ago
Star Tribune sports columnist Sid Hartman dies at age 100 – Minneapolis Star Tribune
- Business2 days ago
The next economic crisis: Empty retail space – POLITICO
- Technology6 hours ago
For $6.99 a month, Google will send you prints of your 10 best photos, as picked by AI – The Verge
- Health1 day ago
Autistic girls going undiagnosed due to ‘camouflaging’ behaviour, study claims – The Guardian
- Technology2 days ago
Google kills off app that let you find loved ones’ location during an emergency – The Verge
- Entertainment18 hours ago
‘Away’ Canceled By Netflix After One Season – Deadline